SVETLANA MEIER MD NPI 1609054659

NPI Information

  • NPI: 1609054659
  • Provider Name: SVETLANA MEIER, MD
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3277 E LOUISE DR
    SUITE 350
    MERIDIAN, ID
    ZIP 83642
  • Phone: (208) 887-9500

Map and Directions

Get Directions

NPI Details

Svetlana Meier, MD is a rheumatology internal medicine in Meridian, ID with 33 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Svetlana Meier, MD NPI is 1609054659. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

3277 E LOUISE DR
SUITE 350
MERIDIAN, ID
ZIP 83642-359
Phone: (208) 887-9500
Fax: (208) 887-9800

The NPI 1609054659 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Complete ultrasound scan of joint (HCPCS:76881)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • Vitamin d-3 level (HCPCS:82306)
  • Uric acid level, blood (HCPCS:84550)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
  • Rheumatoid factor level (HCPCS:86431)
  • Tuberculosis test, gamma interferon (HCPCS:86480)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Aspiration and/or injection of fluid from small joint using ultrasound guidance (HCPCS:20604)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Microsomal antibodies (autoantibody) measurement (HCPCS:86376)
  • Automated urinalysis test (HCPCS:81003)
  • Acute hepatitis panel (HCPCS:80074)
  • Aspiration and/or injection of fluid from medium joint using ultrasound guidance (HCPCS:20606)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Cardiolipin antibody (tissue antibody) measurement (HCPCS:86147)

The enumeration date for this NPI number is 2/1/2008 and was last updated on 1/16/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatologyM-11431IDAHOYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.